Tag:
MP0112
Latest Headlines
Latest Headlines
Allergan snags rights to retinal disease drug in $420M pact
Determined to use its cache of cash to muscle its way further into the market for retinal diseases, Allergan has paid $45 million upfront and promised up to $375 million more in milestones to nab the
